Experimental Drug Found to Be Safe and Effective in Treating Children with MIS-C

Experimental drug found to be safe and effective in treating children with MIS-C

In a small trial, Mass General Brigham researchers found a drug designed to treat Celiac disease supported a more rapid return to normal activities for patients following COVID.

Drug for celiac disease shows promise in treating severe post-COVID syndrome in children

In a small trial, Mass General Brigham researchers have found that a drug designed to treat celiac disease supported a more rapid return to normal activities for patients following COVID.

Drug for coeliac disease may help treat severe post-Covid syndrome...

Last Updated on July 31, 2025 by Team THIP New Delhi, July 31 (IANS) A drug designed to treat coeliac disease — an autoimmune disorder primarily affecting the small intestine — has shown promise for children affected with severe post-Covid syndrome, according to a small study. Covid infection, although rare in kids, leads to multisystem […] The post Drug for coeliac disease may help treat severe post-Covid syndrome in children appeared first on …

Celiac Disease Therapy Provides Benefit for Children With GI Conditions After COVID-19

Larazotide, a therapy known to treat celiac disease, shows promise as a safe treatment for multisystem inflammatory syndrome in children linked to COVID-19, enhancing recovery and symptom resolution.

Novel Drug May Help Speed Kids' GI Recovery in Severe Post-COVID Syndrome

(MedPage Today) — Adding a novel oral drug originally designed to treat celiac disease to standard treatment for post-COVID multisystem inflammatory syndrome in children (MIS-C) appeared safe and effective in a small, phase IIa randomized, double… Source link : https://www.medpagetoday.com/infectiousdisease/covid19/116754 Author : Publish date : 2025-07-30 20:49:00 Copyright for syndicated content belongs to the linked […] The post Novel Drug Ma…